HIV/AIDS-related skin conditions
Learn more about skin conditions that may occur in later stages of HIV/AIDS.
This patient, who lives in a resource-poor area of Africa and lacks access to medications, has an uncommon form of disseminated candidiasis. The majority of patients with HIV will develop one of three forms of mucocutaneous candidiasis: oropharyngeal, esophageal or vulvovaginal. Although easily treated with antifungal medications, candidiasis infections can interfere with medication administration and adequate nutrition intake.
Molluscum contagiosum is a benign superficial skin disease caused by a poxvirus that occurs in children and adults worldwide. Although on average, lesions are 2mm to 5mm in size, patients with HIV/AIDS can develop “giant” lesions that are ≥15mm in diameter; larger numbers of lesions; and lesions that are more resistant to standard therapy.
Oral hairy leukoplakia appears as white corrugated lesions on the tongue & is common among severely immunosupressed patients. Secondary infection with Epstein Barr Virus causes OHL. Lesions are usually asymptomatic but may cause altered taste or discomfort, and are sometimes confused with candidiasis. Specific treatment is generally not necessary, as lesions typically resolve with antiretroviral therapy. If the lesions are ulcerated or unusual, clinicians should biopsy to distinguish from cancer
This patient has experienced weight loss due to muscle wastage associated with AIDS and has seborrheic dermatitis, marked by the darker patches on the skin. Although seborrheic dermatitis occurs throughout the general population, it may be a clinical indication that full-blown AIDS has developed in patients who are HIV seropositive.
Kaposi sarcoma, a type of vascular cancer once only seen in elderly people of Jewish or Mediterranean descent, is one of the two most common opportunistic diseases associated with AIDS. Its spread, however, is an uncommon cause of death; AIDS patients are more likely to succumb to Pneumocystis carinii pneumonia, the other rampant opportunistic infection associated with AIDS.
As of 2009, more than 33.3 million people worldwide have HIV/AIDS. Most live in developing nations, but more than one million live in the US; of these, 21% are unaware of their infection. Most people have few symptoms in the first stages of HIV, but may experience influenza-like illness including fever, headache, tiredness and enlarged lymph nodes around the neck and groin area. Testing for HIV is the only way to identify patients who are infected. Learn more about skin conditions that may occur in later stages of the disease.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|